1 North Wealth Services’s Biogen BIIB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.16K Hold
10
﹤0.01% 276
2026
Q1
$1.83K Hold
10
﹤0.01% 244
2025
Q4
$1.76K Hold
10
﹤0.01% 255
2025
Q3
$1.4K Hold
10
﹤0.01% 240
2025
Q2
$1.26K Hold
10
﹤0.01% 245
2025
Q1
$1.37K Buy
+10
New +$1.43K ﹤0.01% 242
2019
Q4
$3K Hold
10
﹤0.01% 284
2019
Q3
$2K Buy
+10
New +$2.33K ﹤0.01% 277
2019
Q1
$2K Hold
10
﹤0.01% 258
2018
Q4
$3K Buy
+10
New +$3.19K ﹤0.01% 220

Other funds holding BIIB

1 North Wealth Services's BIIB Position: Q2 2026 in Review

1 North Wealth Services held its Biogen (BIIB) position steady in Q2 2026 at 10 shares worth $2.16K. The position accounts for ﹤0.01% of the portfolio, ranked #276.

1 North Wealth Services first reported a position in BIIB in Q4 2018 and has held it in 10 quarters since. The position peaked at $3K in Q4 2019. 1,036 funds tracked by Wall St. Rank hold BIIB as of Q2 2026.

  • 1 North Wealth Services held 10 shares of Biogen worth $2.16K as of Q2 2026.
  • 1 North Wealth Services left its Biogen share count unchanged in Q2 2026.
  • Biogen made up ﹤0.01% of 1 North Wealth Services's portfolio in Q2 2026, its #276 holding.
  • 1 North Wealth Services first reported a position in Biogen in Q4 2018 and has held it in 10 quarters since.
  • 1 North Wealth Services's Biogen position peaked at $3K in Q4 2019.
  • 1,036 funds tracked by Wall St. Rank held Biogen as of Q2 2026.

Based on 1 North Wealth Services's 13F filing for Q2 2026, filed 3 Aug 2026.